Last reviewed · How we verify

NCT04583670: Echo-MG

Point of Care Ultrasound Use by General Practitioners in France (Echo-MG)

Completed Results posted Last updated 20 January 2026
What this trial tests

trial in Point of Care Ultrasound in 655 participants. Completed in 15 July 2024.

Timeline
15 January 2023
Primary endpoint
15 July 2024
15 July 2024

Quick facts

Lead sponsorSorbonne University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment655
Start date15 January 2023
Primary completion15 July 2024
Estimated completion15 July 2024
Sites17 locations across France

Conditions studied

Sponsor

Sorbonne University

Who can join

Eligibility, any sex, with Point of Care Ultrasound. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Patients With Change in the Diagnosis After POCUS Examination Primary · 20 to 30 minute consultation

GPs will register their diagnoses before and after the use of POCUS and a change in diagnosis will be described * one main diagnostic hypothesis * other diagnostic hypotheses After the use of POCUS, the GPs are asked if these diagnoses have changed and specify.

GroupValue95% CI
Physical Examination of Patients With Ultrasound397
Number of Patients With Change in Diagnostic Confidence Primary · 30 minutes

The GPs are asked to register any change in their confidence in the diagnostic hypothesis after the use of POCUS by choosing one of the following variables on an ordinal scale: increased confidence, more confident, unchanged confidence, less confident, reduced confidence

GroupValue95% CI
Physical Examination of Patients With Ultrasound552
Number of Patients With Change in the Referral Plan Primary · 20 to 30 minute consultation

Before using POC-US: * acute admission to hospital * subacute referral to hospital * normal referral to hospital * subacute referral to specialist * normal referral to specialist * referral for radiology * other referral (e.g. to physiotherapist, etc) * follow-up in the clinic * no plan for follow-up * other After using POC-US the GP is shown the "before POC-US plan for the patient" and asked if this plan has changed. If the plan has changed, the GP is asked to specify.

GroupValue95% CI
Physical Examination of Patients With Ultrasound363
Number of Patients With Change in the Planned Treatment Primary · 20 to 30 minute consultation

The GPs register their planned treatment before POCUS by choosing one or more of the following categorical variables: * medical treatment * non-medical treatment * no treatment * other After using POCUS, the GP is shown the "before POC-US planned treatment for the patient" and asked if this planned treatment has changed. If the planned treatment has changed, the GP is asked to specify.

GroupValue95% CI
Physical Examination of Patients With Ultrasound215

Sponsor's own description

This study explores how Point of Care Ultrasound (POC-US) is used in general practice in France and how it affects the diagnostic process and treatment of patients. General practitioners (GPs) will register information each time they use POC-US during a one month period. The aim of this study is to describe the use of POCUS and its role in the diagnostic and therapeutic process in general medicine. * Description of the use of POCUS through indication, organs scanned, findings, frequency , time consumption. * Analysis of the role of POCUS in the diagnostic process: change of diagnostic hypotheses and change of certainty in the main diagnostic hypothesis. * Analysis of the role of POCUS in the therapeutic process: change in the care pathway and the therapeutic initial plan. This is an observational study without any intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Sorbonne University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04583670.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing